Takeda Pharmaceutical Company announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first…
Browsing: Therapeutics
The National Health Service (NHS) has released results from a trial study of a multi-cancer early detection test (MCED) named…
NEW YORK – Grail has entered into a research collaboration with nonprofits the Whitman-Walker Institute and Cancer Support Community (CSC)…
BETHESDA, Md. and ALISO VIEJO, Calif., March 17, 2021 /PRNewswire/ — GI OnDEMAND ®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership…
Dispense with everything you know about virtual reality, says Dr. Brennan Spiegel at the start of his new book, VRx: How…
Clinical hypnosis can be an effective therapy for treating inflammatory bowel disease in children, promoting improvements in both symptoms and…
Functional gastrointestinal disorders such as functional dyspepsia and irritable bowel syndrome are very common and show considerable alterations in gut-brain…
Irritable bowel syndrome (IBS) is a gastrointestinal psychosomatic disorder that often develops and worsens with stress. Hence, it is important…
Background: Individual hypnotherapy (IH) is a recognised treatment for irritable bowel syndrome (IBS). However, it is not widely available to patients…
Use of digital cognitive behavioral intervention (dCBI) was associated with statistically and clinically significant improvement in anxiety and depression for…